E

Eton Pharmaceuticals
D

ETON

17.020
USD
0.32
(1.92%)
مغلق
حجم التداول
10,086
الربح لكل سهم
0
العائد الربحي
-
P/E
-113
حجم السوق
456,434,446
أصول ذات صلة
ABT
ABT
2.460
(1.90%)
131.760 USD
AMGN
AMGN
6.28
(2.16%)
296.49 USD
AZN
AZN
0.700
(0.89%)
79.180 USD
BMY
BMY
0.645
(1.35%)
48.465 USD
GSK
GSK
0.105
(0.27%)
39.325 USD
JNJ
JNJ
1.930
(1.10%)
176.650 USD
LLY
LLY
16.80
(2.45%)
701.25 USD
MRK
MRK
1.500
(1.81%)
84.250 USD
NVS
NVS
2.080
(1.70%)
124.210 USD
PFE
PFE
0.055
(0.22%)
25.155 USD
SNY
SNY
0.745
(1.52%)
49.770 USD
المزيد
الأخبار المقالات

العنوان: Eton Pharmaceuticals

القطاع: Healthcare
الصناعة: Drug Manufacturers - Specialty & Generic
Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has four commercial rare disease products, Alkindi Sprinkle for the treatment of adrenocortical insufficiency; Carglumic Acid for the treatment of hyperammonemia, Betaine Anhydrous for the treatment of homocystinuria; and Nitisinone for the treatment of hereditary tyrosinemia type 1 (HT-1). The Company has three additional product candidates in late-stage development: ET-400, ET-600, and ZENEO hydrocortisone autoinjector.